Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department
NCT ID: NCT01900847
Last Updated: 2023-07-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
17 participants
INTERVENTIONAL
2013-06-01
2014-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients are eligible for the study if they come to the Emergency Department and their treating physician decides to treat them with morphine (with certain exceptions such as pregnant patients and patients with eye injuries). They will be given information about participating in the study and if they agree, they will be given the study drug. The study drug will be either ketamine or salt water (saline). If patients continue to be in pain they will continue to receive doses of morphine just as they would if they were not in the study. If the treating physician feels that morphine alone is not enough, they will be free to choose another pain medication as they would normally.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-dose Ketamine for Acute Pain in the Emergency Department
NCT03017248
Ketamine For Acute Treatment of Pain in Emergency Department
NCT02306759
Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department
NCT02916927
Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department
NCT02489630
Patient Satisfaction With Subdissociative Dose Ketamine Versus Morphine for Emergency Department Pain Control
NCT04698772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Morphine and placebo
Patient's will receive morphine during the usual course of their emergency department care and will receive a saline in a volume equivalent to the ketamine administered in the experimental arm of the stuy
Morphine
Dosage of morphine determined by treating physician
placebo
saline of same volume as appropriate weight based dose of ketamine
Morphine and Ketamine
Patient's will receive a 0.3mg/kg dose of ketamine in addition to morphine given in the usual course of emergency department care
Ketamine
0.3mg/kg ketamine
Morphine
Dosage of morphine determined by treating physician
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine
0.3mg/kg ketamine
Morphine
Dosage of morphine determined by treating physician
placebo
saline of same volume as appropriate weight based dose of ketamine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 and over
* determined to require morphine for pain control by treating physician
Exclusion Criteria
* Patient with eye injury or eye pain
* Nontraumatic chest Pain
* Pregnant patients or women of childbearing potential
* Patients allergic to morphine or ketamine
* Patients with known history of narcotic/alcohol abuse or presenting for narcotic medication refill
* Patients with hypertension: diastolic blood pressure \> 100 OR systolic blood pressure \> 180
* Patient whose pain is so severe that they are unable to give informed consent
* Patients who have had bad experiences to prior hallucinations from any origin
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American College of Emergency Physicians
OTHER
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona Health Network University Campus 1501 North Campbell Ave
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Berkman, M. R., Larsen, J., Smith, J., Caldwell, J., Waterbrook, A., Stolz, U., & Denninghoff, K. (2014). 369 Ketamine and Morphine versus Morphine Alone for Treatment of Acute Pain in the Emergency Department. Annals of Emergency Medicine, 64(4), S131-S132.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-0045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.